The Future of Orphan Drugs in the U.S.: Market Growth and Trends Through 2033
The U.S. Orphan Drugs Market Size is Anticipated to Exceed USD 269.60 Billion by 2033, Growing at a CAGR of 12.28% from 2023 to 2033. The U.S. orphan drug market has expanded significantly due to rising rare disease diagnoses and increased FDA approvals. Over 7,000 rare diseases affect more than 30 million people in the U.S., creating […]